Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C10 LIPID MODIFYING AGENTS
C10A LIPID MODIFYING AGENTS, PLAIN
C10AX Other lipid modifying agents
C10AX12 Lomitapide
D09638 Lomitapide mesylate (USAN) <JP/US>
USP drug classification [BR:br08302]
Cardiovascular Agents
Dyslipidemics, Other
Lomitapide
D09638 Lomitapide mesylate (USAN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
218 Hyperlipidemia agents
2189 Others
D09638 Lomitapide mesylate (USAN); Lomitapide mesilate (JAN)
Drug groups [BR:br08330]
Hypolipidemic agent
DG01946 Hypolipidemic agent
DG00362 Lomitapide
D09638 Lomitapide mesylate
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00362 Lomitapide
D09638 Lomitapide mesylate
Drug classes [BR:br08332]
Cardiovascular agent
DG01946 Hypolipidemic agent
D09638 Lomitapide mesylate
Target-based classification of drugs [BR:br08310]
Not elsewhere classified
Organismal systems
Digestive system
MTTP
D09638 Lomitapide mesylate (USAN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D09638
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D09638
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D09638
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D09638
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D09638
Drug groups [BR:br08330]
Hypolipidemic agent
DG01946 Hypolipidemic agent
DG00362 Lomitapide
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00362 Lomitapide